Your browser doesn't support javascript.
loading
ABT-737 is a useful component of combinatory chemotherapies for chronic myeloid leukaemias with diverse drug-resistance mechanisms.
Kuroda, Junya; Kimura, Shinya; Andreeff, Michael; Ashihara, Eishi; Kamitsuji, Yuri; Yokota, Asumi; Kawata, Eri; Takeuchi, Miki; Tanaka, Ruriko; Murotani, Yoshihide; Matsumoto, Yosuke; Tanaka, Hideo; Strasser, Andreas; Taniwaki, Masafumi; Maekawa, Taira.
Affiliation
  • Kuroda J; Division of Haematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, Kamigyo-ku, Kyoto, Japan. junkuro@koto.kpu-m.ac.jp
Br J Haematol ; 140(2): 181-90, 2008 Jan.
Article in En | MEDLINE | ID: mdl-18028486
Subject(s)
Search on Google
Add to My VHL
Print
XML
PubMed Links

Database: MEDLINE Main subject: Sulfonamides / Biphenyl Compounds / Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Drug Resistance, Neoplasm / Antineoplastic Agents / Nitrophenols Language: En Journal: Br J Haematol Year: 2008 Type: Article Affiliation country: Japan
Search on Google
Add to My VHL
Print
XML
PubMed Links

Database: MEDLINE Main subject: Sulfonamides / Biphenyl Compounds / Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Drug Resistance, Neoplasm / Antineoplastic Agents / Nitrophenols Language: En Journal: Br J Haematol Year: 2008 Type: Article Affiliation country: Japan